BioClinica

BioClinica Revenues Flat in ‘09

Thursday, February 11, 2010 06:28 AM

BioClinica reported its fourth quarter and full-year 2009 earnings earlier this week. Service revenues for the quarter were almost flat from the fourth quarter 2008 at $14.9 million. Income from continuing operations was $943,000, or $0.06 per fully diluted share, compared with income of $1.7 million for the same period 2008.

More... »

BioClinica Buys Tourtellotte Solutions for $2.1M

Thursday, September 17, 2009 06:30 AM

BioClinica’s September buying spree continued this week with the announcement that the Newtown, Pa.-based contract research organization (CRO) had purchased technology company Tourtellotte Solutions for $2.1 million in cash, plus additional payments in the form of up to $3.2 million in cash and 350,000 shares of BioClinica common stock if certain milestones are met.

More... »

BioClinica Acquires CardioNow

Tuesday, September 8, 2009 06:21 AM

Newtown, Pa.-based contract research organization (CRO) BioClinica is continuing its efforts toward becoming a clinical trial technology “super brand” with its recent acquisition of the CardioNow unit of Agfa Healthcare.

More... »

BioClinica Profits Fall 50%, Continues to Seek Acquisitions

Wednesday, August 5, 2009 06:58 AM

BioClinica’s revenues and profits continued to fall in the second quarter, with net income sliced by half from the same period in 2008 to $529,000. Diluted earnings per share were $0.04 compared with $0.10 in the second quarter 2008. Revenues for the Newtown, Pa.-based contract research organization (CRO) also dropped 11% to $17.1 million.

More... »

Etrials Pays $500K to Terminate Agreement with BioClinica

Wednesday, June 3, 2009 07:00 AM

Only days after BioClinica increased its purchase offer to acquire etrials Worldwide and the two companies agreed to proceed with their acquisition agreement, that agreement has been terminated.

More... »

BioClinica Increases Offer to Buy etrials Worldwide

Thursday, May 21, 2009 08:30 AM

BioClinica, formerly Bio-Imaging Technologies, increased the value of its offer to acquire troubled eClinical vendor etrials Worldwide in response to an unsolicited offer received by etrials from an unrelated third party.

More... »

etrials Cuts Costs—and Losses in Q1

Wednesday, May 13, 2009 08:58 AM

eClinical vendor etrials Worldwide cut its net loss for the first quarter 2009 in half from the same period 2008 by reducing operating expenses, the company said. Net loss for Q1 was $960,000, compared with $2 million in Q1 2008—and $5.5 million in the fourth quarter 2008.

More... »

BioClinica Profits Down, Revenues Up Due to Acquisition

Wednesday, May 6, 2009 10:07 AM

BioClinica, the recently renamed and rebranded Bio-Imaging Technologies, reported a 31% drop in profit for the first quarter 2009 compared with the same period last year. Net income decreased from $1.14 million, or $0.09 per diluted share, in 2008, to $786,000, or $0.05 per diluted share, for Q1 2009.

More... »

Bio-Imaging to Acquire etrials

Tuesday, May 5, 2009 08:40 AM

Only a week after Bio-Imaging Technologies announced a name change to BioClinica and alluded to future acquisitions, the contract research organization (CRO) announced this morning its intent to acquire troubled eClinical vendor etrials Worldwide.

More... »

Bio-Imaging Technologies Changes Name to BioClinica, Expects to Acquire More Companies

Tuesday, April 28, 2009 09:05 AM

Now that Newtown, Pa.-based contract research organization Bio-Imaging Technologies has completed its integration of Phoenix Data Systems, which it acquired in March 2008, the company has changed its name to BioClinica. The new name also marks the start of an active acquisition phase for the 450-employee company, which plans to acquire more companies in the clinical research services space.

More... »